Nura Bio Secures $140M in Series A Financing and Appoints Shilpa Sambashivan, Ph.D., as CEO
Key Highlights Nura Bio closes $140M Series A financing to support clinical development. Shilpa Sambashivan, Ph.D., appointed as CEO following…
Browsing Tag
Samsara Bio Capital
1 post